Announcements Trials
Browse Landscape

Phase

Phase NA 20Phase 3 1Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Motor Activity 4Neoplasms 2Weight Loss 1Myasthenia Gravis 1Lung Neoplasms 1Leukemia 1Gynecologic Cancer 1Gastrointestinal Neoplasms 1Cardiotoxicity 1Cachexia 1Breast Neoplasms 1

Interventions

Radiotherapy 38Carboplatin 37pembrolizumab 36Cisplatin 34Paclitaxel 26Pemetrexed 24Docetaxel 18Nivolumab 17Gemcitabine 17Bevacizumab 17Specimen Handling 16Magnetic Resonance Spectroscopy 16Cyclophosphamide 15osimertinib 14Irinotecan 13Etoposide 13Radiation 12Erlotinib Hydrochloride 12durvalumab 11Topotecan 10Cetuximab 10Radiosurgery 8Immunoglobulin G 8Fluorouracil 8Everolimus 8Disulfides 8Celecoxib 8fludarabine 7Taxes 7Ipilimumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Lung Neoplasms × Exercise × Clear all
NCT04131426 2023-08-15

Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia

University of Rochester

Phase 1 Completed
25 enrolled
GastrointestinalThoracic

Cachexia, Gastrointestinal Neoplasms, Lung Neoplasms, Motor Activity, Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡